Literature DB >> 8897180

Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

F Blasi1, F Denti, M Erba, R Cosentini, R Raccanelli, A Rinaldi, L Fagetti, G Esposito, U Ruberti, L Allegra.   

Abstract

Recent reports suggest an association between Chlamydia pneumoniae and Helicobacter pylori bacteria and atherosclerosis. We studied 51 patients (mean age, 68.3 years) who underwent abdominal aortic aneurysm surgery. For each patient we performed a microimmunofluorescence test for immunoglobulin G (IgG), IgA, and IgM antibodies to C. pneumoniae specific antigen (TW-183). Anti-H. pylori antibodies were determined by means of an EIA-G test. Each aortic aneurysm surgical specimen was sampled into multiple sections of 0.3 cm2 each and frozen at -20 degrees C. Two samples of each aneurysm were used for a nested PCR with two sets of C. pneumoniae and two sets of H. pylori specific primers. Specimens were treated with a solution containing 20 mM Tris-HCl, Tween 20-Nonidet P-40 (0.5% [vol/vol] each), and 100 micrograms of proteinase K per ml and incubated at 60 degrees C for 1 h and at 98 degrees C for 10 min. DNA was extracted twice with phenol-chloroform-isoamylic alcohol and precipitated with sodium acetate-ethanol by standard methods. Forty-one patients were seropositive for C. pneumoniae with past-infection patterns in 32 patients (16 < or = IgG < 512; 32 < or = IgA < 256) and high antibody titers in 9 patients (IgG > or = 512). In 26 of 51 patients, C. pneumoniae DNA was detected in aortic aneurysm plaque specimens. Of these patients, 23 had a serologic past-infection pattern, 2 had an acute reinfection pattern, and 1 was seronegative. Forty-seven of 51 patients were seropositive for H. pylori. In all cases PCR showed no evidence of H. pylori presence in plaque specimens. This study provides data on a possible C. pneumoniae involvement in the pathogenesis of aortic aneurysm and additional evidence for an association between this agent and atherosclerosis. Conversely, notwithstanding a high H. pylori seroprevalence observed, our results tend to rule out the possibility of a direct involvement of H. pylori in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897180      PMCID: PMC229401          DOI: 10.1128/jcm.34.11.2766-2769.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.

Authors:  M Kleemola; P Saikku; R Visakorpi; S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

3.  Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test.

Authors:  S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1970-09       Impact factor: 5.258

4.  Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients.

Authors:  D H Spodick; A P Flessas; M M Johnson
Journal:  Am J Cardiol       Date:  1984-02-01       Impact factor: 2.778

5.  Acute myocardial infarction precipitated by infectious disease.

Authors:  E Pesonen; O Siitonen
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

6.  Pneumonia associated with the TWAR strain of Chlamydia.

Authors:  T J Marrie; J T Grayston; S P Wang; C C Kuo
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

7.  High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis.

Authors:  E Adam; J L Melnick; J L Probtsfield; B L Petrie; J Burek; K R Bailey; C H McCollum; M E DeBakey
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

8.  Coxsackie B virus antibodies in myocardial infarction.

Authors:  J Nikoskelainen; J L Kalliomäki; K Lapinleimu; M Stenvik; P E Halonen
Journal:  Acta Med Scand       Date:  1983

9.  Viruses in the etiology of atherosclerosis.

Authors:  E P Benditt; T Barrett; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population.

Authors:  D H Thom; J T Grayston; S P Wang; C C Kuo; J Altman
Journal:  Am J Epidemiol       Date:  1990-08       Impact factor: 4.897

View more
  49 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

Authors:  P Apfalter; F Blasi; J Boman; C A Gaydos; M Kundi; M Maass; A Makristathis; A Meijer; R Nadrchal; K Persson; M L Rotter; C Y Tong; G Stanek; A M Hirschl
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 3.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

4.  Is Helicobacter pylori a factor in coronary atherosclerosis?

Authors:  J Danesh; J Koreth; L Youngman; R Collins; J R Arnold; Y Balarajan; J McGee; D Roskell
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 5.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 6.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

7.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

8.  Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis.

Authors:  M Maurin; F Eb; J Etienne; D Raoult
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

9.  Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis.

Authors:  J Bishara; S Pitlik; A Kazakov; G Sahar; M Haddad; A Vojdani; S Rosenberg; Z Samra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-09       Impact factor: 3.267

10.  A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.

Authors:  Shuhui Zheng; Lingli Long; Yonghao Li; Yuxia Xu; Zhang Jiqin; Weidong Ji; Wang Min
Journal:  Cardiovasc Pharm Open Access       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.